A Study to Compare the Efficacy and Safety of LY01015 and Opdivo® Combined Respectively With Chemotherapy in Advanced or Metastatic Esophageal Squamous Cell Carcinoma
Clinical trial NCT06022861 · RECRUITING
Trial details
- NCT number
- NCT06022861
- Sponsor
- Shandong Boan Biotechnology Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-12
- Primary completion
- 2025-06-01
- Enrollment
- 510
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.